Results 121 to 130 of about 106,623 (304)
British Journal of Clinical Pharmacology, EarlyView.Aims GLP‐1 medicines provide substantial cardio‐renal benefits for type 2 diabetes (T2D) and are increasingly used for weight loss. Most high‐income countries subsidize access for T2D with restrictions; use outside of these restrictions occurs through private prescriptions. Despite strong consumer demand, the extent of private access to GLP‐1 medicines
Michael O. Falster +10 more
wiley +1 more source
Evolution of Culture on Patient Safety in the Clinical Setting of a Spanish Mutual Insurance Company: Observational Study between 2009 and 2017 Based on AHRQ Survey. [PDF]
Int J Environ Res Public Health, 2021 Ulibarrena MÁ +7 more
europepmc +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Non‐adherence to oral anticoagulants (OACs) is associated with significant morbidity and mortality. Mobile health (mHealth) interventions have been used to improve medication adherence across the three phases of initiation, implementation and persistence.
Non Davies +2 more
wiley +1 more source
A History of the Afro-American Life Insurance Company [PDF]
Brochure: A history of the Afro-American Insurance Company. See page 2 Disaster Strikes section for information on Eartha White\u27s role in the company.
Afro-American Life Insurance Company
core
Environmental impact of antidepressants: Is a new prescription framework possible?
British Journal of Clinical Pharmacology, EarlyView.Aims Antidepressants such as venlafaxine and sertraline pose high risks to water ecosystems. As depressive disorders and other mental health conditions become increasingly prevalent worldwide, prescription and environmental presence of these pharmaceuticals continue to rise. This study explores the practical viability of a new framework for prescribing
Matilde Bianconi +5 more
wiley +1 more source
Toward clone‐on‐a‐chip: Ethical and legal considerations for organ‐on‐a‐chip evolution
BMEMat, EarlyView.The term “clone‐on‐a‐chip (CoC)” is introduced as a conceptual warning for personalized organ‐on‐a‐chip platforms and not to suggest technological feasibility, where a CoC ethical discussion extends beyond issues arising from the requirements for informed consent, property rights, commercialization efforts, and cell sourcing to include potentially ...
Muhammed Erkan Karabekmez +6 more
wiley +1 more source
Letter to Robert Nelles from the Office of the N.D. Mutual Fire Insurance Company [PDF]
Letter to Robert Nelles from the Office of the N.D. Mutual Fire Insurance Company regarding an assessment of 5% on the premium notes of this company. This is signed by Mr. Arnold, secretary of the N.D. Mutual F. Insurance Company, Dec.
N.D. Mutual Insurance Company
core
A letter from Washington national Insurance Company to Dr. Hector P. Garcia, informing him of an upcoming policy change. [PDF]
, 1984 A letter from Washington national Insurance Company to Dr. Hector P.
Washington National Insurance Company
core
Pravo, 2016 The carriers` liability for losses on goods in the road transport results from the contract of carriage concluded with the party who ordered the transport.
Radivoj Kovač
doaj
Planning of marketing activity in an insurance company [PDF]
Marketing i Menedžment Innovacij, 2012 In the article theoretical approaches in relation to planning of marketing activity in an insurance company are examined. Stages of marketing activity planning in insurance company are offered.
Е.A. Smirnova
doaj